Anti-NMDAR antibody detection material, preparation method and application thereof, kit using detection material and detection method
Patent Information
- Application Number
- CN202411178121.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-11-12
AI Technical Summary
[0005]上述技术通过瞬时转染令细胞大量表达NMDAR,会导致相关离子的过度流入及流出,从而引发细胞损伤和死亡
本申请通过添加艾芬地尔(Ifenprodil)以抑制NMDAR离子通道的活性,从而提高抗NMDAR抗体检测结果的可靠性。本申请的技术方案可用于辅助临床以及科研使用。
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of antibody detection, and in particular to an anti-NMDAR antibody detection material and a preparation method and application thereof, a kit using the detection material, and a detection method. Background Art
[0002] N-methyl-D-aspartate receptor (NMDAR) is an ion channel type glutamate receptor with key electrophysiological properties and regulatory mechanisms in the central nervous system. The activation of NMDAR depends on the binding of glutamate. As a neurotransmitter, glutamate binds to the binding sites of GluN1 and GluN2 subunits on NMDAR, inducing channel opening. The ion channel of NMDAR is highly selective, allowing sodium ions (Na + ) and calcium ions (Ca 2+ ) flow into the cell, while potassium ions (K + ) out of the cell.
[0003] The related art discloses an anti-NMDAR antibody detection material. The reagent includes a slide reagent, a fluorescently labeled secondary antibody, and a phosphate buffer; the slide reagent includes NMDAR transfected cells expressing a labeled fluorescent protein and blank vector transfected cells expressing a labeled fluorescent protein; the fluorescence in the fluorescently labeled secondary antibody and the NMDAR transfected cells expressing the fluorescent protein are of different color systems. Through the fluorescence of different color systems and fluorescence combinations, it is used to determine whether the sample contains the target antibody.
[0004] The preparation method of the above-mentioned anti-NMDAR antibody detection material is as follows: 1) Cultivate NMDAR transfected cells expressing mCherry-tagged and blank vector transfected cells expressing mCherry-tagged on a plate matrix, observe the cell growth under a microscope, and wait until the cells grow to nearly 100%; 2) Remove the culture medium and wash with 1×PBS for 2-3 minutes each time; 3) Add 50μL of 4% paraformaldehyde (fixative) to fix the cells for 60 minutes, discard the fixative, add 50μL of 1×PBS to wash twice, each time for 2-3 minutes; 4) Add 50μL of 5% BSA (blocking solution) to block for 20 minutes, discard the blocking solution, add 50μL of 1×PBS to wash twice, each time for 2-3 minutes, and dry; 5) Transfer the dried cell-laden plate matrix to a slide and fix it with shadowless glue.
[0005] The above technology uses transient transfection to make cells express NMDAR in large quantities, which will lead to excessive influx and outflow of related ions, thereby causing cell damage and death. If the number of transfected cells decreases and the abundance of NMDAR expression decreases, it will eventually make it difficult to conduct strict quality control of the test materials, which may lead to differences between test results and make it difficult to set unified diagnostic standards.
[0006] Therefore, the detection of anti-NMDAR antibodies in the related art has poor sensitivity and accuracy. Summary of the invention
[0007] In order to improve the sensitivity and accuracy of anti-NMDAR antibody detection, the present application provides an anti-NMDAR antibody detection material and a preparation method and application thereof.
[0008] In a first aspect, the present application provides a use of Ifenprodil in an anti-NMDAR antibody detection material.
[0009] In a second aspect, the present application provides a method for preparing an anti-NMDAR antibody detection material, using the following technical solution: A method for preparing an anti-NMDAR antibody detection material, the preparation method specifically comprising the following steps: (1) Construction of a recombinant plasmid carrying the NMDAR target gene fragment; (2) transfecting the recombinant plasmid into cells and culturing them at low temperature to obtain cell slides expressing the NMDAR gene; the cells are HEK 293T cells; The culture medium used for culturing at low temperature is a complete culture medium supplemented with Ifenprodil; Within 5-8 hours after transfection, the culture medium used for transfection is replaced with the culture medium used for culturing at the low temperature; The temperature used for the low temperature culture is 25-35°C, and the culture time is 48-72h; (3) first fixing the cell slide expressing the NMDAR gene with a fixing solution, and then protecting the cell slide expressing the NMDAR gene with a protein protecting agent, thereby obtaining an anti-NMDAR antibody detection material; The protein protectant is a mixed solution consisting of saccharides with a mass concentration of 2-15% and protease inhibitors with a molar concentration of 0.1-1.0 mmol / L.
[0010] This application co-transfects NMDAR1\NMDAR2B two-sequence plasmids to make NMDAR expression closer to the physiological state and have more complete and diverse antigenic determinants. However, its higher ion channel activity makes it difficult for cells to survive after transfection. This application adds Ifenprodil to inhibit the activity of NMDAR ion channels, thereby improving the reliability of anti-NMDAR antibody detection results. The technical solution of this application can be used to assist clinical and scientific research use.
[0011] The present application can fully enrich the transfected protein by adopting a low-temperature culture method in the process of preparing the detection material. Prolonging the expression and membrane transport time after transfection can increase the expression of NMDAR receptors in transfected cells and increase the abundance of membrane receptors, thereby effectively improving the accuracy and sensitivity of the detection material for sample detection.
[0012] This application uses protective agents to improve reagent stability: protein protective agents can inhibit protease activity, prevent protein degradation, and interact with protein molecules through hydrogen bonds and ions to enhance protein stability. Through this interaction, the structure of the protein can be maintained and it is not easy to denature or aggregate.
[0013] Optionally, the amount of Ifenprodil added to the complete culture medium is 50-200 μM.
[0014] Optionally, the temperature during the preparation of the anti-NMDAR antibody detection material is no higher than 35°C.
[0015] Alternatively, the present application co-transfects NMDAR1\NMDAR2B sequence plasmids to make NMDAR expression closer to the physiological state and have more complete and diverse antigenic determinants. However, its higher ion channel activity makes it difficult for cells to survive after transfection.
[0016] Optionally, the fixing liquid is selected from a solution prepared by any one or more of aldehydes, methanol, ethanol, acetone, osmium tetroxide, picric acid, chloroform, chromic acid, mercuric chloride, and dichromic acid.
[0017] In a third aspect, the present application provides an anti-NMDAR antibody detection material, which is prepared using the above-mentioned preparation method.
[0018] Optionally, when the sample is tested using the test material, the temperature of the test process is no higher than 35°C.
[0019] Optionally, the detection process is carried out at room temperature.
[0020] In a fourth aspect, the present application provides an application of an anti-NMDAR antibody detection material in the preparation of a product for detecting anti-NMDAR antibodies.
[0021] In a fifth aspect, the present application provides a CBA detection kit. The CBA detection kit comprises the above-mentioned anti-NMDAR antibody detection material.
[0022] In a sixth aspect, the present application provides a CBA detection method using the above-mentioned anti-NMDAR antibody detection material, which adopts the following technical solution: A CBA detection method using the above-mentioned anti-NMDAR antibody detection material, the detection method specifically comprises the following steps: Add the sample to the reaction well of the anti-NMDAR antibody detection material and react in the dark; then wash with buffer and soak in a dye vat. After the reaction, take out and discard the liquid in the reaction well; continue to add fluorescent secondary antibody and continue to react in the dark; then wash with buffer, add sealing medium and observe the results.
[0023] In summary, the present application includes at least one of the following beneficial technical effects: The present application adds Ifenprodil to inhibit the activity of NMDAR ion channels, thereby improving the reliability of anti-NMDAR antibody detection results. The technical solution of the present application can be used to assist clinical and scientific research use.
[0024] The present application can fully enrich the transfected protein by adopting a low-temperature culture method in the process of preparing the detection material. Prolonging the expression and membrane transport time after transfection can increase the expression of NMDAR receptors in transfected cells and increase the abundance of membrane receptors, thereby effectively improving the accuracy and sensitivity of the detection material for sample detection. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 These are pictures of the preparation process of the anti-NMDAR antibody detection material of the present application ((a) shows the anti-NMDAR antibody detection material after cutting; (b) shows a mosaic board with the anti-NMDAR antibody detection material after cutting pasted).
[0026] Figure 2 The test results of the test material of Example 1 on day 0 (initial state) are stored.
[0027] Figure 3 This is the test result of the test material prepared in Example 1 on positive serum (Ifenprodil was added during the preparation process, and the low-temperature culture condition was 32° C. for 72 h).
[0028] Figure 4 This is the test result of the test material prepared in Comparative Example 1 on positive serum (Ifenprodil was not added during the preparation process).
[0029] Figure 5 The test results of the test material prepared in Comparative Example 2 on positive serum (culture conditions were 37°C for 30 hours).
[0030] Figure 6 The test results of the test material of Example 1 were stored for 3 months.
[0031] Figure 7 The test results of the test material of Comparative Example 2 were stored for 3 months. DETAILED DESCRIPTION
[0032] Before describing the embodiments of the present application in detail, it should be understood that the terms used herein are only used for the purpose of describing specific embodiments. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by ordinary technicians in the field to which the terms belong.
[0033] It should be noted that the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Therefore, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features. Further, in the description of this application, unless otherwise specified, the meaning of "plurality" is two or more.
[0034] The endpoints and any values of the ranges disclosed in this application are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.
[0035] In the present application, the terms "comprise" or "include" are open expressions, that is, including the contents specified in the present application but not excluding other contents.
[0036] The present application provides the use of Ifenprodil in anti-NMDAR antibody detection materials. Ifenprodil is added in the process of preparing anti-NMDAR antibody detection materials to inhibit the activity of NMDAR ion channels, thereby improving the reliability of anti-NMDAR antibody detection results.
[0037] The present application also provides an anti-NMDAR antibody detection material and a preparation method and application thereof.
[0038] The preparation method specifically comprises the following steps: (1) Obtain the target gene and insert the target gene with restriction site into the plasmid to obtain a recombinant plasmid with the target gene.
[0039] The nucleotide sequence of the target gene includes NMDAR1 and NMDAR2B; the NMDAR1 includes the nucleotide sequence shown in SEQ ID NO.1; the NMDAR2B includes the nucleotide sequence shown in SEQ ID NO.2.
[0040] (2) Transfect the recombinant plasmid into HEK 293T cells to obtain recombinant plasmid-293T cells.
[0041] (3) The recombinant plasmid-293T cells were cultured at low temperature to enrich NMDAR expression.
[0042] The culture medium used for culturing at low temperature was complete culture medium supplemented with Ifenprodil.
[0043] The amount of Ifenprodil added to the complete culture medium is 50-200 μM.
[0044] The temperature used for cultivation under low temperature is 25-35°C and the cultivation time is 48-72h.
[0045] Within 5-8 hours after transfection, the medium used for transfection was replaced with the medium used for culture at low temperature.
[0046] (4) After removing the culture medium from the recombinant plasmid-293T cells cultured at low temperature, wash them with phosphate buffer; fix them with a fixative, remove the fixative, and wash them with phosphate buffer; protect them with a protein protectant, remove the protein protectant, and dry them to obtain the anti-NMDAR antibody detection material.
[0047] The temperature during the preparation of the anti-NMDAR antibody detection material is no higher than 35°C.
[0048] In order to make the purpose, technical scheme and advantages of the present application clearer, the technical scheme in the embodiments of the present application will be clearly and completely described below in conjunction with the accompanying drawings. Based on the embodiments of the present application, all other embodiments obtained by those skilled in the art without making creative work belong to the scope of protection of the present application. The embodiments described below are exemplary and are only used to explain the present application, and cannot be understood as limiting the present application.
[0049] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.
[0050] The present application is further described in detail below in combination with embodiments, comparative examples and test results.
[0051] Example 1 This embodiment provides an anti-NMDAR antibody detection material.
[0052] The preparation method of the above anti-NMDAR antibody detection material specifically comprises the following steps: 1. Construction of recombinant plasmids carrying target genes The CDS sequence of the NMDAR gene obtained by artificial synthesis or PCR method is used as the target gene, and SalI / NotI restriction sites are added at both ends of the target gene to obtain the target gene with restriction sites. Then the target gene with restriction sites is inserted into the pShuttle-cmv plasmid to obtain a recombinant plasmid with the target gene.
[0053] Among them, the CDS sequence of the NMDAR gene includes NMDAR1 and NMDAR2B; the NMDAR1 includes the nucleotide sequence shown in SEQ ID NO.1; the NMDAR2B includes the nucleotide sequence shown in SEQ ID NO.2.
[0054] (II) Preparation of recombinant plasmid-293T cells (1) HEK 293T cell culture: DMEM high glucose medium (Sigma) and FBS (Sigma) were prepared at a volume ratio of 9:1 to prepare FBS-DMEM high glucose medium with 10% FBS, and HEK 293T cells were inoculated; when HEK 293T cells were confluent, they were passaged at a ratio of 1:5 to a 10 cm slide containing a glass slide. 2 The culture dish was placed in a cell culture incubator at 37°C and 5% CO2 for overnight culture.
[0055] (2) Transfection: 2 μg of the constructed recombinant plasmid carrying the target gene was transfected into the 293T cells obtained by subculture using a transfection reagent (lipofectamin2000) to obtain recombinant plasmid-293T cells.
[0056] 3. Low temperature culture enriches NMDAR expression 6 h after transfection, the culture medium was replaced with complete culture medium (Sigma) supplemented with 100 μM Ifenprodil and transferred to low-temperature culture: 32°C for 72 h to enrich NMDAR expression.
[0057] 4. Preparation of anti-NMDAR antibody detection materials The culture medium of the recombinant plasmid-293T cells cultured at low temperature was removed, and PBS buffer was added to rinse the cell slides for 3 times; the washed cell slides were placed in a fixative (4% paraformaldehyde fixative) and fixed for 10 minutes.
[0058] After fixation, remove the fixative, add 1 mL of PBS buffer to rinse 3 times, and wash the fixative; add a special protein protectant, protect for 5-10 minutes, absorb the protein protectant, and obtain the CBA antigen piece, which is the anti-NMDAR antibody detection material. The effective ingredients of the protein protectant are trehalose with a mass concentration of 10%, sucrose with a mass concentration of 5%, and PMSF with a molar concentration of 0.1 mmol / L.
[0059] Add desiccant and place in a drying room to dry. All subsequent steps should be completed in a drying room with constant temperature and humidity. Cut the dried anti-NMDAR antibody detection material, paste it on a 4-well mosaic plate, and store it for a long time at 4-8°C.
[0060] like Figure 1 As shown, Figure 1 (a) shows the anti-NMDAR antibody detection material after cutting, and (b) shows the mosaic plate with the anti-NMDAR antibody detection material after cutting pasted.
[0061] Comparative Example Comparative Example 1 This comparative example provides an anti-NMDAR antibody detection material.
[0062] The difference between the preparation method of the above anti-NMDAR antibody detection material and Example 1 is that in the preparation method of the detection material of this comparative example, the culture medium was not replaced with a complete culture medium supplemented with 100 μM Ifenprodil 6 hours after transfection, and the rest was consistent with the preparation method of Example 1.
[0063] Comparative Example 2 This comparative example provides an anti-NMDAR antibody detection material.
[0064] The difference between the preparation method of the above anti-NMDAR antibody detection material and Example 1 is that in the preparation method of the detection material of this comparative example, the culture temperature is 37° C. and the culture time is 30 h, and the rest is consistent with the preparation method of Example 1.
[0065] Comparative Example 3 This comparative example provides an anti-NMDAR antibody detection reagent.
[0066] The difference between the preparation method of the above anti-NMDAR antibody detection reagent and that of Example 1 is that: in the preparation method of the detection reagent of this comparative example, no protein protective agent is used, and the rest is consistent with the preparation method of Example 1.
[0067] Test 1 The samples were tested using the test materials of the embodiment and the comparative example respectively. The samples could be 10-fold diluted serum samples or undiluted cerebrospinal fluid samples.
[0068] The detection method using the above detection materials is as follows: (1) Soak the prepared anti-NMDAR antibody detection material in PBS buffer for 5 min. After the soaking, remove and discard the liquid in the reaction well.
[0069] (2) Add 10-fold diluted serum samples to the reaction wells of the anti-NMDAR antibody detection material in sequence, 50 μL per well, and place in a wet box for reaction for 30 min.
[0070] (3) After the reaction is completed, use PBS buffer to gently rinse the sample in the reaction well from one side and soak it in the dye tank for 5 minutes. After the reaction is completed, remove and discard the liquid in the reaction well.
[0071] (4) Add 50 μL of fluorescent secondary antibody (goat anti-human IgG secondary antibody labeled with fluorescent Dylight 488) to the reaction well, and ensure that the fluorescent secondary antibody is in good contact with the reaction well. Place in a wet box for reaction for 30 minutes, and avoid light throughout the reaction process.
[0072] (5) Repeat step (3) and add mounting medium (a mixture of glycerol and PBS buffer in a ratio of 1:1 (v:v)) to the reaction wells and carefully cover with a coverslip to avoid bubbles.
[0073] (6) Observe the results under a fluorescence microscope.
[0074] The test results of Example 1 and Comparative Examples 1-2 are as follows: Figure 3-5 shown.
[0075] By comparison Figure 3 and Figure 4 The test results show that Figure 4 The cells in the middle part died in patches, and almost no positive cells were seen, indicating that a large number of transfected cells were damaged and died. Figure 3 It can be seen that the cells are in good condition. There are obvious positive cells. This shows that the present application introduces Ifenprodil in the preparation method of the anti-NMDAR antibody detection material, which can effectively reduce cell death, thereby improving the accuracy and sensitivity of the anti-NMDAR antibody detection material for sample detection.
[0076] By comparison Figure 3 and Figure 5 The test results show that Figure 5 The number of positive cells that can be seen in the Figure 3There are many positive cells with high brightness and complete morphology. It is explained that the present application can fully enrich the transfected protein by low-temperature culture in the preparation method of the anti-NMDAR antibody detection material. Prolonging the expression and membrane transport time after transfection can increase the expression of NMDAR receptors in transfected cells and increase the abundance of membrane receptors, thereby effectively improving the accuracy and sensitivity of the detection material for sample detection. The present application adopts 25-35°C conditions for cell culture, which can significantly slow down the cell proliferation rate, while the cell protein expression is less affected. It is beneficial to prolong the cell culture time after transfection and increase the expression of transfected proteins.
[0077] Test 2 The sample was tested using the test material of Example 1 on the 0th day of storage. The test method was the same as that in Test 1. The test results are as follows: Figure 2 shown.
[0078] The samples were tested using the test materials of Example 1 and Comparative Example 3 after being stored for 3 months. The test method was the same as that in Test 1. The test results are shown in Figure 6 and Figure 7 shown.
[0079] By comparing the test results, it can be seen that a protein protective agent was used in the preparation process of the detection reagent provided in Example 1 to protect the target protein. However, no protective agent was used in the detection reagent of Comparative Example 2. Figure 2 , 6 and Figure 2 , 7 It can be seen that the application of protective agents can significantly improve protein stability, make the cell morphology of the detection reagent staining results more complete, and reduce the brightness less. It can improve the stability of the antigen and extend the shelf life of the detection reagent. The detection reagent provided in this application has a shelf life of at least 3 months.
[0080] The temperature of each link in the preparation process of the detection material of Example 1 was controlled, and the temperature did not exceed 35°C. The incubation temperature during the preparation process of the detection material of Comparative Example 2 was 37°C. Figure 6 It can be seen that by controlling the temperature and humidity in each link during the preparation of the detection material, the cell morphology of the staining results of the detection material is more complete, which can not only improve the stability of the antigen, but also extend the shelf life of the detection material. The shelf life of the detection material provided in this application is at least more than 3 months.
[0081] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example" or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present application. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.
[0082] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present application, rather than to limit it. Although the present application has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present application.
Claims
1. Application of Ifenprodil in anti-NMDAR antibody detection materials.
2. A method for preparing an anti-NMDAR antibody detection material, It is characterized in that The preparation method specifically comprises the following steps: (1) Construction of a recombinant plasmid carrying the NMDAR target gene fragment; (2) transfecting the recombinant plasmid into cells and culturing them at low temperature to obtain cell slides expressing the NMDAR gene; the cells are HEK 293T cells; The culture medium used for culturing at low temperature is a complete culture medium supplemented with Ifenprodil; Within 5-8 hours after transfection, the culture medium used for transfection is replaced with the culture medium used for culturing at the low temperature; The temperature used for the low temperature culture is 25-35°C, and the culture time is 48-72h; (3) first fixing the cell slide expressing the NMDAR gene with a fixing solution, and then protecting the cell slide expressing the NMDAR gene with a protein protecting agent, thereby obtaining an anti-NMDAR antibody detection material; The protein protectant is a mixed solution consisting of saccharides with a mass concentration of 2-15% and protease inhibitors with a molar concentration of 0.1-1.0 mmol / L.
3. The preparation method according to claim 2, It is characterized in that The amount of Ifenprodil added to the complete culture medium is 50-200 μM.
4. The preparation method according to claim 2, It is characterized in that The temperature during the preparation of the anti-NMDAR antibody detection material is no higher than 35°C.
5. The preparation method according to claim 2, It is characterized in that The nucleotide sequence of the target gene includes NMDAR1 and NMDAR2B; the NMDAR1 includes the nucleotide sequence shown in SEQ ID NO. 1; the NMDAR2B includes the nucleotide sequence shown in SEQ ID NO.
2.
6. An anti-NMDAR antibody detection material, It is characterized in that The anti-NMDAR antibody detection material is prepared by the preparation method described in any one of claims 2-5.
7. The anti-NMDAR antibody detection material according to claim 6, It is characterized in that When the sample is tested using the test material, the temperature during the test is no higher than 35°C; Optionally, the detection process is carried out at room temperature.
8. Use of the anti-NMDAR antibody detection material according to claim 6 in preparing a product for detecting anti-NMDAR antibodies.
9. A CBA detection kit, It is characterized in that The CBA detection kit comprises the anti-NMDAR antibody detection material according to claim 6.
10. A CBA detection method using the anti-NMDAR antibody detection material according to any one of claims 6-7, It is characterized in that The detection method specifically includes the following steps: adding a sample to the reaction well of the anti-NMDAR antibody detection material for light-proof reaction; then washing with a buffer solution, soaking in a dye vat, taking out and discarding the liquid in the reaction well after completion; continuing to add a fluorescent secondary antibody to continue the light-proof reaction; then washing with a buffer solution, adding a sealing medium, and observing the results.
